摘要
目的探究产妇采用舒芬太尼与罗哌卡因联合镇痛模式对其产程及阴道助产的影响与效果。方法选择2017年1月～2018年1月我院所收治的产妇82例,采用随机数字表法将其分为实验组与参照组,每组均41例。其中,参照组采用经阴道无痛分娩方式,实验组实施舒芬太尼与罗哌卡因联合镇痛模式。对比2组产妇疼痛感、分娩相关数据、助产情况及不良反应。结果实验组分娩时疼痛视觉模拟评分明显低于参照组,两者差异明显(P<0.05)。实验组与参照组第一产程、第二产程、第三产程时长、出血量及新生儿阿氏评分无显著差异(P>0.05)。实验组与参照组注射缩宫素及产钳助产比例无显著差异(P>0.05)。实验组(14.63%)轻度不良反应发生率高于参照组(0%),两者差异明显(P<0.05)。结论采用舒芬太尼与罗哌卡因联合镇痛模式,产妇分娩疼痛感得以有效控制,且对产妇产程及阴道助产不会造成影响,药物不良反应轻微,应予以临床推广。
Objective To discusss the effect of using sufentanil combining ropivacaine to treat labor analgesia on stages of labor and vaginal midwifery rate.Methods Choosed 82 puerpera from Jan.2017 to Jan.2018 to divide into study group and controlled group with 41 cases in each.The controlled group were treated with vaginal painless delivery,the study group were treated with sufentanil combining ropivacaine.Compared the pain degree,midwifery rate and incidence of adverse effects.Results The VAS scores of study group was lowe than controlled group （P〈0.05）.And the stages of labor ,bleeding,and apgar scores of study group were no difference with controlled group （P〉0.05）.And the rate of using oxytocin and midwifery rate of study group were no difference with controlled group （P〉0.05）.And the incidence of adverse effects of study group was higher than controlled group （P〈0.05）.Conclusion Using sufentanil combining ropivacaine can treat labor analgesia on stages of labor with mild adverse effects to extend in clinic.
作者
李杰
li Jie(Qionglai Maternal and Child Health Family Planning Service Center,Department of Anesthesiology,Qionglai Maternal and Child Health Hospital,Sichuan Chengdu 611530,China)
出处
《实用妇科内分泌电子杂志》
2018年第29期6-8,共3页
Electronic Journal of Practical Gynecological Endocrinology
